Name | 1-(7-bromo-3,4-dihydro-1h-isoquinolin-2-yl)-2,2,2-trifluoroethanone |
---|---|
Synonyms |
Ethanone, 1-(7-bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-
7-bromo-2-trifluoroacetyl-1,2,3,4-tetrahydroisoquinoline 1-(7-Bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoroethanone |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 392.9±42.0 °C at 760 mmHg |
Molecular Formula | C11H9BrF3NO |
Molecular Weight | 308.095 |
Flash Point | 191.4±27.9 °C |
Exact Mass | 306.981964 |
PSA | 20.31000 |
LogP | 4.02 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.533 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2933499090 |
~85% 181514-35-2 |
Literature: NOVARTIS AG Patent: WO2008/76954 A2, 2008 ; Location in patent: Page/Page column 51 ; WO 2008/076954 A2 |
~94% 181514-35-2 |
Literature: Stokker Tetrahedron Letters, 1996 , vol. 37, # 31 p. 5453 - 5456 |
~% 181514-35-2 |
Literature: Taisho Pharmaceutical Co., Ltd.; BUSUJIMA, Tsuyoshi; OI, Takahiro; TANAKA, Hiroaki; SHIRASAKI, Yoshihisa; IWAKIRI, Kanako; SATO, Nagaaki; TOKITA, Shigeru Patent: EP2687507 A1, 2014 ; Location in patent: Paragraph 0209 ; |
~% 181514-35-2 |
Literature: Stokker Tetrahedron Letters, 1996 , vol. 37, # 31 p. 5453 - 5456 |
~% 181514-35-2 |
Literature: Pfizer Inc Patent: US2005/182079 A1, 2005 ; Location in patent: Page/Page column 11 ; |
Precursor 6 | |
---|---|
DownStream 1 | |
HS Code | 2933499090 |
---|---|
Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |